BIO logo

BIO

Bio-Rad Laboratories Inc. Class A

$296.90
+$9.16(+3.18%)
60
Overall
75
Value
63
Tech
42
Quality
How is this score calculated?
Market Cap
$7.52B
Volume
454.70K
52W Range
$211.43 - $343.12
Target Price
$296.25

Latest News for BIO

Biome Australia starts international multi-centre trial for first proprietary probiotic strain
TipRanks Australian Auto-Generated Newsdeskin 2 hoursMay 27, 2026

Biome Australia Ltd ( ($AU:BIO) ) has shared an announcement. Biome Australia has launched a multi-centre, randomised, double-blind, placebo-contro......

Biome Australia to spotlight BMB18 clinical program and IP strategy in June investor webinar
TipRanks Australian Auto-Generated Newsdesk3 hours agoMay 26, 2026

The latest announcement is out from Biome Australia Ltd ( ($AU:BIO) ). Biome Australia will host a 30-minute investor webinar on 5 June 2026 to out......

Sobi’s Tryngolza cuts pancreatitis risk 85% in severe hypertriglyceridemia trial analysis
TipRanks Sweden Auto-Generated Newsdesk13 hours agoMay 26, 2026

An announcement from Swedish Orphan Biovitrum AB ( ($SE:SOBI) ) is now available. Sobi reported new pooled Phase 3 data showing that its RNA-target......

Analysts Have Conflicting Sentiments on These Healthcare Companies: Bio-Rad Laboratories (BIO) and Haleon PLC Sponsored ADR (HLN)
Brian Anderson2 days agoMay 25, 2026

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Bio-Rad Laboratories (BIO) and Haleon PLC Sponsore......

Jefferies Keeps Their Hold Rating on Bio-Rad Laboratories (BIO)
TipRanks Auto-Generated Intelligence Newsdesk6 days agoMay 21, 2026

Jefferies analyst Tycho Peterson maintained a Hold rating on Bio-Rad Laboratories today and set a price target of $275.00. According to TipRanks, P......

Jefferies Keeps Their Hold Rating on Bio-Rad Laboratories (BIO)
TipRanks Auto-Generated Intelligence Newsdesk6 days agoMay 21, 2026

Jefferies analyst Tycho Peterson maintained a Hold rating on Bio-Rad Laboratories today and set a price target of $275.00. According to TipRanks, P......

Insiders Buy the Dip in These 2 Crushed Stocks With Strong Buy Ratings
Michael Marcus6 days agoMay 21, 2026

The oldest rule in investing is simple – buy low and sell high. The challenge, of course, is figuring out which beaten-down stocks are genuinely br......

BridgeBio Pharma (BBIO) Gets a Hold from Citi
TipRanks Auto-Generated Intelligence Newsdesk7 days agoMay 19, 2026

BridgeBio Pharma received a Hold rating and price target from Citi analyst today. In addition to Citi, BridgeBio Pharma also received a Hold from J......

Zenas BioPharma Advances Phase 3 Orelabrutinib Trial in Tough MS Segment
TipRanks Clinical-Trials-Auto-Generated Newsdesk8 days agoMay 18, 2026

Zenas BioPharma, Inc. ($ZBIO) announced an update on their ongoing clinical study. This phase 3 study, titled “A Phase 3, Randomized, Double-blind,......

Zenas BioPharma Advances Phase 3 Orelabrutinib Trial in Tough MS Segment
TipRanks Clinical-Trials-Auto-Generated Newsdesk8 days agoMay 18, 2026

Zenas BioPharma, Inc. ($ZBIO) announced an update on their ongoing clinical study. This phase 3 study, titled “A Phase 3, Randomized, Double-blind,......

News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 41 articles.

ABCD
1SymbolPriceChangeVol
2BIO$296.90+3.2%454.70K
3
4
5
6

Get Bio-Rad Laboratories Inc. Class A Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.